Tony Mok, MD
Tony Mok has been selected by the American Society of Clinical Oncology (ASCO) as a candidate for the 2017 ASCO Board of Directors. Professor Mok is a professor in the Department […] Read more
Richard B. Gaynor, MD
Richard B. Gaynor will retire as Senior Vice President, Global Development and Medical Affairs, Lilly Oncology as of January 2017. Prior to joining Lilly, Dr. Gaynor was a professor of medicine […] Read more
Martin J. Edelman, MD
Martin J. Edelman has been appointed Chairman of the Department of Hematology/Oncology and Deputy Director for Clinical Research at the Fox Chase Cancer Center in Philadelphia. He will also be the […] Read more
Dr. Philip Bonomi, MD
Dr. Philip Bonomi completed his service as Director of the Division of Hematology, Oncology and Cell Therapy at Rush University Medical Center, Chicago, US, a position he has held since […] Read more
David Ball, MD, FRANZCR
David Ball was appointed Director of the Lung Tumour Stream for The Royal Melbourne Hospital, The Royal Women’s Hospital and the Peter MacCallum Cancer Centre, which are now part of […] Read more
Robert B. Livingston, MD
The lung cancer research community lost a respected leader and significant contributor to the field with the passing of Robert B. Livingston, MD, a Professor of Medicine and Hematology-Oncology at […] Read more
Glen Weiss, MD, MBA
Glen Weiss, MD, MBA, was named 2016 Healthcare Leadership Awards’ Researcher of the Year by AZ Business magazine. Dr. Weiss is Director of Clinical Research, Director of Phase I and II […] Read more
David Spigel, MD
David Spigel has been appointed chief scientific officer of Sarah Cannon Research Institute, Nashville, US, and will oversee the development and operations of Sarah Cannon’s clinical research program. Dr. Spigel joined […] Read more
Mark A. Socinski, MD
Mark A. Socinski has been appointed Executive Medical Director of the Florida Hospital Cancer Institute, and will oversee the coordination of clinical cancer services for the Florida Hospital network. He will […] Read more
David H. Johnson, MD
David H. Johnson received the 2016 ASCO Distinguished Achievement Award, which is given annually and recognizes leadership or mentorship by a scientist, practitioner, or researcher who has benefited patients with cancer […] Read more